Advertisement
UK markets close in 3 hours 9 minutes

  • FTSE 100

    8,118.40
    +39.54 (+0.49%)
     

  • FTSE 250

    19,805.24
    +203.26 (+1.04%)
     

  • AIM

    754.69
    +1.57 (+0.21%)
     

  • GBP/EUR

    1.1669
    +0.0013 (+0.11%)
     

  • GBP/USD

    1.2509
    -0.0002 (-0.01%)
     

  • Bitcoin GBP

    51,452.38
    +288.39 (+0.56%)
     

  • CMC Crypto 200

    1,387.44
    -9.10 (-0.65%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.33
    +0.76 (+0.91%)
     

  • GOLD FUTURES

    2,355.40
    +12.90 (+0.55%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,049.96
    +132.68 (+0.74%)
     

  • CAC 40

    8,041.87
    +25.22 (+0.31%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·32-min read
Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation fourth-quarter and year-end 2020 financial results and corporate update conference call. Good morning, and thank you for joining the Arbutus Biopharma fourth-quarter 2020 conference call and webcast. On the call today are Bill Collier, president and chief executive officer; Dr. Gaston Picchio, chief development officer; Dr. Michael Sofia, chief scientific officer; and Dave Hastings, chief financial officer.

Continue reading